Medidata’s Julie Iskow Honored Among PharmaVOICE 100’s Most Inspiring People
August 24 2017 - 8:30AM
Business Wire
Medidata (NASDAQ:MDSO), the leading global provider of
cloud-based technology and data analytics for clinical research, is
pleased to announce that Julie Iskow, executive vice president and
chief technology officer, has been recognized by PharmaVOICE
magazine as one of the 100 most inspiring people in the life
sciences industry.
Julie Iskow was named to the prestigious list for her technical
insight, transformational leadership and steadfast dedication to
providing innovative technology that helps Medidata customers and
partners worldwide accelerate hope for patients.
Since assuming her role at Medidata in 2015, Julie has leveraged
her more than 20 years of experience in designing and developing
cloud and SaaS applications, to lead the company’s technology
efforts. She has succeeded in managing the growth of her team at
Medidata collectively by almost 40%. Her department is responsible
for the continued innovation and enhancement of the Medidata
Clinical Cloud® — which has demonstrated unparalleled success in
the market, including its widespread adoption, high customer
retention rate and industry accolades. To date, the Medidata
Clinical Cloud has supported approximately 13,000 studies and 3.7
million trial subjects, and 13 of the top 15 selling drugs globally
were developed using Medidata technology.
“Julie is a transformational leader, whose technological
insights and steadfast dedication to improving healthcare is
helping Medidata combine cutting-edge tools and important data to
help solve some of the most challenging problems for life-sciences
companies,” says Taren Grom, editor of PharmaVOICE. “And her deep
understanding for the need for greater collaboration to achieve
innovation are just a few of the reasons why she is a 2017
PharmaVOICE 100 honoree.”
Recently named a 2017 Luminary by the Healthcare Businesswomen’s
Association (HBA), Julie is helping Medidata to augment its
cutting-edge solutions by incorporating important data and insights
to solve big problems for global life sciences companies. At a time
when clinical trial complexity and spend are at an all-time high,
the importance of Julie’s role has never been more paramount.
This year’s distinguished honorees were nominated by thousands
of PharmaVOICE readers and were selected for inclusion based on
substantive accounts describing how they have inspired or motivated
their colleagues, peers, and even competitors; their positive
impact on patients, their organizations, and the industry at large;
their innovative and game-changing strategies and thinking; their
mentorship and guidance to the next generation of leaders; as well
as their willingness to give their time and resources to their
communities and philanthropic causes. Iskow becomes the thirteenth
Medidata leader to be named to the PharmaVOICE 100.
“Julie is constantly looking for new and better ways to tackle
today’s biggest challenges for the life sciences industry,“ said
Mike Capone, Medidata’s chief operating officer. “She is incredibly
deserving of this award, and we are thrilled that PharmaVOICE has
recognized her passion and drive to deliver technology that will
ultimately help the most important customer of all: the
patient.”
About Medidata
Medidata is reinventing global drug and medical device
development by creating the industry's leading cloud-based
solutions for clinical research. Through our advanced applications
and intelligent data analytics, Medidata helps advance the
scientific goals of life sciences customers worldwide, including
over 850 global pharmaceutical companies, biotech, diagnostic and
device firms, leading academic medical centers, and contract
research organizations.
The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled
clinical trial data assets provide deep insights that pave the way
for future growth. The Medidata Clinical Cloud is the primary
technology solution powering clinical trials for 18 of the world's
top 25 global pharmaceutical companies and is used by 18 of the top
25 medical device developers—from study design and planning through
execution, management and reporting.
About PharmaVOICE
PharmaVOICE: Published monthly, with the combined July/August
PharmaVOICE 100 and November/December Year in Preview issues,
PharmaVOICE is expressly written and designed to deliver the views,
opinions, and insights of the executives who are shaping the
direction of the dynamic and multifaceted life-sciences industry.
PharmaVOICE reaches more than 41,000 BPA qualified subscribers and
60,000 users with its digital edition. PharmaVOICE’s unique
horizontal editorial approach cuts across industry silos, providing
a holistic overview of the life-sciences industry, addressing a
range of topics from molecule through market. By engaging
compelling personalities from diverse industry sectors, PharmaVOICE
provides multiple perspectives on business challenges, trends, and
topics. Editorial content sparks dialog, initiates debate, and
opens the lines of communication to facilitate and improve
business-to- business relationships. PharmaVOICE’s
multiple-perspective and in-depth original forums, feature
articles, topics, and departments are audience-driven. PharmaVOICE
provides executives with useful peer-to-peer insights on a broad
range of business practices and topics to a wide range of
life-science sectors.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170824005566/en/
Medidata SolutionsInvestors:Anthony D’Amico,
+1-732-767-4331adamico@mdsol.comorMedia:Erik Snider,
+1-646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Sep 2023 to Sep 2024